Sharmila Shankar

Summary

Affiliation: University of Kansas Medical Center
Country: USA

Publications

  1. ncbi Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
    Sanjit K Roy
    Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    J Mol Signal 5:10. 2010
  2. ncbi The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
    Su Ni Tang
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    J Mol Signal 5:14. 2010
  3. ncbi MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo
    Rakesh K Srivastava
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Mol Cancer Ther 9:3254-66. 2010
  4. ncbi Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells
    Rakesh K Srivastava
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, USA
    Front Biosci (Elite Ed) 3:515-28. 2011

Collaborators

  • Rakesh K Srivastava
  • Su Ni Tang
  • Daniel Meeker
  • Sanjit K Roy
  • Wenyu Zhu
  • Chandan Singh
  • Razelle Kurzrock
  • Dara Nall

Detail Information

Publications4

  1. ncbi Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer
    Sanjit K Roy
    Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    J Mol Signal 5:10. 2010
    ....
  2. ncbi The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition
    Su Ni Tang
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA
    J Mol Signal 5:14. 2010
    ....
  3. ncbi MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo
    Rakesh K Srivastava
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, Kansas 66160, USA
    Mol Cancer Ther 9:3254-66. 2010
    ....
  4. ncbi Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells
    Rakesh K Srivastava
    Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, USA
    Front Biosci (Elite Ed) 3:515-28. 2011
    ..These data suggest that SFN either alone or in combination with quercetin can eliminate cancer stem cell-characteristics...